Cell and gene therapy has moved from breakthrough science to clinical reality, but the next challenge is clear: how to scale, commercialize, and deliver these therapies without breaking the system.
Innovation is accelerating. But infrastructure, economics, and regulation are struggling to keep pace, with manufacturing bottlenecks, high costs, and access barriers limiting impact.
New approaches – from AI-enabled bioprocessing to allogeneic platforms – are starting to shift what’s possible.
This event brings together leaders across biotech, pharma, CDMO, and clinical development to explore what it will take to move cell and gene therapy from promise to standard of care.
Discover the Future of Cell & Gene Therapies—From Regulatory Shifts to Real-World Impact
- Learn how leading organizations are overcoming manufacturing bottlenecks and scaling cell and gene therapy production.
- Explore innovative reimbursement and pricing strategies that can support long-term commercial viability.
- Discover approaches to expanding patient access and accelerating the path from clinical trial to treatment.
- Stay ahead of evolving regulatory requirements and emerging expectations across global markets.
- Gain practical insights from innovators driving the next phase of cell and gene therapy commercialization.
Benefits of Attending
Audience Networking
Q&A
